BioRestorative Therapies replaced CBIZ CPAs with Bush & Associates CPA and appointed Anna Skowron as fractional CFO at a $12,000 monthly fee. The changes affect the company’s independent audit and principal financial officer roles, while Mika Grasso becomes interim CEO and Katharyn Field moves into advisory and transition services.
Key Highlights
- Anna Skowron will serve as BioRestorative Therapies’ non-employee, fractional CFO and treasurer through BPC Consulting Ltd.
- Katharyn Field resigned from the Board effective August 31, 2026, after stepping aside from executive roles.
- Mika Grasso became interim CEO, while Steven Brown was appointed chairman of the Board.
The company will pay its newly appointed fractional CFO’s consulting firm $12,000 per month, while its outgoing interim finance chief will provide transition services for $10,000 monthly.
Bush CPA Takes Over 2026 Audit CBIZ’s
engagement ran from April 16, 2025, through August 28, 2026, when BioRestorative Therapies (NASDAQ: BRTX) ended the relationship. The Board approved the auditor change on August 26, 2026, and the Audit Committee approved and ratified it on September 1, 2026. Bush CPA’s engagement also took effect August 28, 2026, following Board approval on August 26 and Audit Committee approval on September 1. The company said Bush CPA had not previously advised it on accounting principles, audit opinions or matters involving a disagreement or reportable event during the relevant period. Katharyn Field stepped aside as interim CEO and CFO on August 26, 2026, ceased serving as interim CFO and treasurer on August 27, and left the Board on August 31. Her consulting arrangement pays EEAK Consulting LLC $10,000 monthly plus applicable taxes for advisory and transition services. Steven Brown became Audit Committee chair and was appointed Board chairman on September 1, 2026. The Board also designated Brown as its audit committee financial expert and reconstituted its Audit, Compensation, and Nominating and Corporate Governance committees.
Peers Moving on This News
- Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) up 1.4%
- Apimeds Pharmaceuticals US, Inc. (AMEX: APUS) down 4.6%



Please wait processing your request...